| Rowcaps |
|---|
| Rows 1-2: | This shows 2 observations (base pathological processes) for injection site 1 (in FOCID). The finding is standardized when mapping to the controlled terminology in MISTRESC, MICHRON, MIDISTR, MISEV, and any additional modifiers in MIRESMOD (SUPPMI example). | | Row 3: | A second injection site (in FOCID) on the same animal was also examined. | |
| Dataset2 |
|---|
| Row | STUDYID | DOMAIN | USUBJID | FOCID | MISEQ | MITESTCD | MITEST | MIORRES | MISTRESC | MICHRON | MIDISTR | MISPEC | MISPCCND | MISPCUFL | MISEV | MIDTC | MIDY |
|---|
| 1 | ABC | MI | ABC-101 | Injection Site 1 | 1 | GHISTXQLMicroscopic Examination | General Histopathologic Exam, Qual | Subcutaneous Inflammation, Minimal | INFLAMMATION |
|
| SITE, INJECTION |
|
| MINIMAL | 2015-10-27 | 42 | | 2 | ABC | MI | ABC-101 | Injection Site 1 | 2 | GHISTXQLMicroscopic Examination | General Histopathologic Exam, Qual | Panniculus Muscle-Inflammation/Degeneration, Focal, Slight | INFLAMMATION/ DEGENERATION |
| FOCAL | SITE, INJECTION |
|
| MILD | 2015-10-27 | 42 | | 3 | ABC | MI | ABC-101 | Injection Site 2 | 3 | GHISTXQLMicroscopic Examination | General Histopathologic Exam, Qual | Subcutaneous Hemorrhage, Minimal | HEMORRHAGE |
|
| SITE, INJECTION |
|
| MINIMAL | 2015-10-27 | 42 | |
|